AmberLeeBeitelsheesPharmD, MPH

Amber Lee Beitelshees, MPH is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

206 citations
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, Rhonda M. Cooper-DeHoff, Julio D. Duarte
JACC. Cardiovascular Interventions. 2018-01-22
75 citations
Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide
Stephen Turner, Eric Boerwinkle, Jeffrey R. O'Connell, Kent R. Bailey, Yan Gong
Hypertension. 2013-08-01
89 citations
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
Philip E. Empey, James M. Stevenson, Sony Tuteja, Kristin Weitzel, Dominick J. Angiolillo
Clinical Pharmacology and Therapeutics. 2018-10-01

Journal Articles

Prescribing Prevalence of Medications with Potential Genotype-Guided Dosing in Pediatric Patients
Amber L Beitelshees, Philip E Empey, Christopher M Horvat, Jeffrey R Bishop, JAMA Network Open

Uncoupling Protein Polymorphisms And Cardiometabolic Responses To Beta-BlockersNational Heart, Lung, And Blood Institute2008–2011
Pathway Pharmacogenetics And Angiotensin Receptor Blocker ResponsesNational Center For Research Resources2009
Uncoupling Protein Polymorphisms And Cardiometabolic Responses To Beta-BlockersNational Heart, Lung, And Blood Institute2008
Telmisartan PharmacogeneticsNational Center For Research Resources2007

Office
670 W Baltimore St, Room 4172
Baltimore, MD 21201
Phone+1 410-706-0118